您使用提示模式 关闭

WHEA - SPDR® MSCI World Health Care UCITS ETF (USD) (IE00BYTRRB94)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.
 
(%)
IE00BYTRRB94
WHEA ISIN
交易所交易基金 (ETF)
基金类型
SPDR State Street Global Advisors
提供商
65,2 USD
每股资产净值 | 2026-04-16
2016-04-29
成立日期
股息的支付
CEOGMS
CFI
WHEA
代码
Formed
Status
Equity
投资项目
Healthcare
部门
Global
地区分布
MSCI World Health Care Index
基准
0.3 %
总成本比率
451,04 百万 USD
基金资产总量 | 2022-10-24
580,46 百万 USD
股票类资产 | 2026-04-16
UCITS

收益率 在 2026-06-18, Euronext Amsterdam

  • YTD
    -4,22 %
  • 1M
    -1,89 %
  • 3M
    -6,4 %
  • 6M
    -3,3 %
  • 1Y
    9,07 %
  • 3Y
    4,95 %
  • 5Y
    26,89 %
  • 10Y
    -
按交换价格计算,包括收入支付

最新数据在
最新数据在 2026-04-16
添加比较项目

报价 (WHEA)

探索最全面的数据库

1 000 000

债券

80 234

股票

167 970

ETF & Funds

8万

指数

以最有效的方式跟踪您的投资组合

  • 债券筛选器
  • 观察列表
  • Excel 附加组件

价格动态的变化

Fund profile

The SPDR MSCI World Health Care UCITS ETF seeks to replicate as closely as possible the price and yield performance of the MSCI World Health Care 35/20 Capped Index by investing in a portfolio comprised primarily of equity securities of healthcare companies across developed market countries

WHEA profile

The SPDR® MSCI World Health Care UCITS ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in Global. The SPDR State Street Global Advisors fund’s base currency is USD and the share class was registered 29.04.2016 with unique ISIN - IE00BYTRRB94. Main exchange is Euronext Amsterdam and ticker symbol is WHEA. The total expense ratio is 0.3%. The SPDR® MSCI World Health Care UCITS ETF (USD) pays dividends 0 time(s) per year.

结构 WHEA 在 2026-06-18

证券
Eli Lilly and Company 11,57%
Johnson & Johnson 7,21%
AbbVie Inc. 5,02%
UnitedHealth Group Incorporated 4,78%
Merck & Co. Inc. 3,69%
Roche Holding Ltd 3,66%
Novartis AG 3,53%
AstraZeneca PLC 3,45%
Amgen Inc. 2,39%
Thermo Fisher Scientific Inc. 2,26%
Abbott Laboratories 2,02%
Gilead Sciences Inc. 2,01%
Intuitive Surgical Inc. 1,9%
Pfizer Inc. 1,88%
Novo Nordisk A/S Class B 1,82%
CVS Health Corporation 1,64%
Vertex Pharmaceuticals Incorporated 1,51%
Danaher Corporation 1,48%
Bristol-Myers Squibb Company 1,45%
Stryker Corporation 1,39%
GSK plc 1,35%
Medtronic Plc 1,34%
Sanofi SA 1,21%
McKesson Corporation 1,21%
Elevance Health Inc. 1,12%
Cigna Group 0,96%
Boston Scientific Corporation 0,88%
Regeneron Pharmaceuticals Inc. 0,83%
EssilorLuxottica SA 0,81%
HOYA CORPORATION 0,79%
HCA Healthcare Inc 0,77%
argenx SE 0,71%
Cardinal Health Inc. 0,69%
Cencora Inc. 0,66%
Edwards Lifesciences Corporation 0,66%
Takeda Pharmaceutical Co. Ltd. 0,65%
IDEXX Laboratories Inc. 0,58%
Humana Inc. 0,56%
Lonza Group AG 0,56%
Bayer AG 0,55%
Becton Dickinson and Company 0,54%
Galderma Group AG 0,53%
Haleon PLC 0,52%
CSL Limited 0,49%
Teva Pharmaceutical Industries Limited Sponsored ADR 0,48%
Alnylam Pharmaceuticals Inc 0,48%
Agilent Technologies Inc. 0,47%
Waters Corporation 0,46%
Sandoz Group Ltd 0,46%
UCB S.A. 0,46%
Zoetis Inc. Class A 0,43%
Alcon AG 0,43%
Chugai Pharmaceutical Co. Ltd. 0,42%
Natera Inc. 0,41%
Centene Corporation 0,39%
Biogen Inc. 0,38%
Daiichi Sankyo Company Limited 0,38%
IQVIA Holdings Inc 0,37%
Otsuka Holdings Co. Ltd. 0,37%
GE Healthcare Technologies Inc. 0,37%
DexCom Inc. 0,37%
ResMed Inc. 0,36%
Revolution Medicines Inc. 0,35%
Illumina Inc. 0,32%
West Pharmaceutical Services Inc. 0,32%
Astellas Pharma Inc. 0,3%
Mettler-Toledo International Inc. 0,3%
Veeva Systems Inc Class A 0,29%
Royalty Pharma Plc Class A 0,29%
Koninklijke Philips N.V. 0,29%
Quest Diagnostics Incorporated 0,28%
Labcorp Holdings Inc. 0,28%
United Therapeutics Corporation 0,27%
Insmed Incorporated 0,26%
STERIS plc 0,26%
Merck KGaA 0,26%
Fresenius SE & Co. KGaA 0,25%
Terumo Corporation 0,25%
Zimmer Biomet Holdings Inc. 0,22%
Incyte Corporation 0,22%
Genmab A/S 0,2%
Neurocrine Biosciences Inc. 0,2%
Straumann Holding AG 0,19%
Medline Inc. Class A 0,17%
Siemens Healthineers AG 0,17%
Cooper Companies Inc. 0,17%
Fisher & Paykel Healthcare Corporation Limited 0,17%
Shionogi & Co. Ltd. 0,17%
Sonova Holding AG 0,16%
Roche Holding Ltd 0,16%
Smith & Nephew plc 0,15%
Olympus Corp. 0,15%
Sigma Healthcare Ltd 0,13%
Insulet Corporation 0,13%
Fresenius Medical Care AG 0,12%
Orion Oyj Class B 0,12%
Swedish Orphan Biovitrum AB 0,11%
Eurofins Scientific SE 0,1%
QIAGEN NV 0,1%
Coloplast A/S Class B 0,09%
Other - %

其他 ETF 和基金提供商

相关 ETF 和基金

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} 百万
    资产净值
    {{ item.expense_ratio }}
    总成本比率
你必须 注册 才能获得访问权